To include your compound in the COVID-19 Resource Center, submit it here.

Acorda misses Street

Acorda Therapeutics Inc. (NASDAQ:ACOR) fell $3.23 (12%) to $23.93 on Thursday after reporting 1Q11

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE